These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29470971)

  • 1. Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases.
    Ali TK; Gibbons A; Cartes C; Zarei-Ghanavati S; Gomaa M; Gonzalez I; Gonzalez AE; Ozturk HE; Betancurt C; Perez VL
    Am J Ophthalmol; 2018 May; 189():65-70. PubMed ID: 29470971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingerprick Autologous Blood in the Treatment of Severe Dry Eyes and Ocular Surface Disease.
    Erikitola OO; Williams O; Fern A; Lyall D
    Cornea; 2021 Sep; 40(9):1104-1109. PubMed ID: 33369936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease.
    Hussain M; Shtein RM; Sugar A; Soong HK; Woodward MA; DeLoss K; Mian SI
    Cornea; 2014 Dec; 33(12):1245-51. PubMed ID: 25299423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous serum application in the treatment of neurotrophic keratopathy.
    Matsumoto Y; Dogru M; Goto E; Ohashi Y; Kojima T; Ishida R; Tsubota K
    Ophthalmology; 2004 Jun; 111(6):1115-20. PubMed ID: 15177961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes.
    Huang FC; Tseng SH; Shih MH; Chen FK
    Ophthalmology; 2002 Oct; 109(10):1934-40. PubMed ID: 12359618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study.
    Giannaccare G; Buzzi M; Fresina M; Velati C; Versura P
    Cornea; 2017 Aug; 36(8):915-921. PubMed ID: 28679130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.
    Azari AA; Karadag R; Kanavi MR; Nehls S; Barney N; Kim K; Longo W; Hematti P; Juckett M
    Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood derived treatment from two allogeneic sources for severe dry eye associated to keratopathy: a multicentre randomised cross over clinical trial.
    Campos E; Versura P; Buzzi M; Fontana L; Giannaccare G; Pellegrini M; Lanconelli N; Brancaleoni A; Moscardelli F; Sebastiani S; Vaselli C; Randi V
    Br J Ophthalmol; 2020 Aug; 104(8):1142-1147. PubMed ID: 31744796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy.
    Chahal JS; Heur M; Chiu GB
    Eye Contact Lens; 2017 Jul; 43(4):240-244. PubMed ID: 27171131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease.
    Cheng AMS; Tighe S; Sheha H; Tseng SCG
    Int Ophthalmol; 2018 Oct; 38(5):2219-2222. PubMed ID: 29101724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology.
    Shtein RM; Shen JF; Kuo AN; Hammersmith KM; Li JY; Weikert MP
    Ophthalmology; 2020 Jan; 127(1):128-133. PubMed ID: 31561880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of dry eye related to systemic diseases in childhood and longterm follow-up.
    Mac Cord Medina F; Silvestre de Castro R; Leite SC; Rocha EM; de Melo Rocha G
    Acta Ophthalmol Scand; 2007 Nov; 85(7):739-44. PubMed ID: 17559557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease.
    Basu S; Shanbhag SS; Gokani A; Kedar R; Bahuguna C; Sangwan VS
    Am J Ophthalmol; 2018 May; 189():17-28. PubMed ID: 29421293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E; Asfuroğlu E
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders.
    Merayo-Lloves J; Sanchez RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
    Ophthalmic Res; 2015; 55(2):53-61. PubMed ID: 26569104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.